Loading
SP
SCOLR Pharma, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by TAGLICH MICHAEL N, was filed 19 Mar 2009.
SCOLR Pharma, Inc.: what insiders have been doing
Every trade that managers of SCOLR Pharma, Inc. disclose to SEC (Form 4) is tracked on this page. Nothing new has been filed by managers of SCOLR Pharma, Inc. in twelve months, the latest record being from 6 January 2010.
Looking back to 2006, when coverage begins, insiders filed 61 purchases and 64 sales.
Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
142
Thresholds
n/a
Buy Volume
€291,966
61 ops. · all time
Sell Volume
€465,610
64 ops. · all time
Last declaration on 6 January 2010
Declarations142 total
214,285 shares0Common StockSEC:0001209191-10-001905:0
2,500 shares@ US$0.25Common StockSEC:0001181431-09-016417:0
Canonical exit: 15 Jun 2009 (T+90)
300 shares@ US$0.84Common StockSEC:0001181431-08-062988:0
Canonical exit: 17 Feb 2009 (T+90)
1,500 shares@ US$0.85Common StockSEC:0001181431-08-062988:1
Canonical exit: 17 Feb 2009 (T+90)
100 shares@ US$0.87Common StockSEC:0001181431-08-062988:2
Canonical exit: 17 Feb 2009 (T+90)
500 shares@ US$0.90Common StockSEC:0001181431-08-062988:3
Canonical exit: 17 Feb 2009 (T+90)
500 shares@ US$0.91Common StockSEC:0001181431-08-062988:4
Canonical exit: 17 Feb 2009 (T+90)
1,900 shares@ US$0.95Common StockSEC:0001181431-08-062988:5
Canonical exit: 17 Feb 2009 (T+90)
200 shares@ US$0.98Common StockSEC:0001181431-08-062988:6
Canonical exit: 17 Feb 2009 (T+90)
3,000 shares@ US$0.89Common StockSEC:0001181431-08-061343:0
Canonical exit: 10 Feb 2009 (T+90)
5,000 shares@ US$0.89Common StockSEC:0001181431-08-061352:0
Canonical exit: 10 Feb 2009 (T+90)
4,300 shares@ US$0.90Common StockSEC:0001181431-08-061010:0
Canonical exit: 9 Feb 2009 (T+90)
100 shares@ US$0.91Common StockSEC:0001181431-08-061010:1
Canonical exit: 9 Feb 2009 (T+90)
100 shares@ US$0.92Common StockSEC:0001181431-08-061010:2
Canonical exit: 9 Feb 2009 (T+90)
11,700 shares@ US$0.93Common StockSEC:0001181431-08-061010:3
Canonical exit: 9 Feb 2009 (T+90)
8,800 shares@ US$0.94Common StockSEC:0001181431-08-061010:4
Canonical exit: 9 Feb 2009 (T+90)
3,500 shares@ US$1.10Common StockSEC:0001181431-08-035828:0
Canonical exit: 28 Aug 2008 (T+90)
1,500 shares@ US$1.09Common StockSEC:0001181431-08-035828:1
Canonical exit: 28 Aug 2008 (T+90)
1,700 shares@ US$1.04Common StockSEC:0001181431-08-035456:0
Canonical exit: 28 Aug 2008 (T+90)
800 shares@ US$1.05Common StockSEC:0001181431-08-035456:1
Canonical exit: 28 Aug 2008 (T+90)
1,100 shares@ US$1.06Common StockSEC:0001181431-08-029725:0
Canonical exit: 5 Aug 2008 (T+90)
1,400 shares@ US$1.07Common StockSEC:0001181431-08-029725:1
Canonical exit: 5 Aug 2008 (T+90)
50,000 shares@ US$1.00Common StockSEC:0001181431-08-018667:0
39,526 shares@ US$1.00Common StockSEC:0001181431-08-018667:1
17,000 shares0Common StockSEC:0001181431-08-009878:0
25 of 142 declarations
About SCOLR Pharma, Inc.
SCOLR Pharma, Inc. is a company focused on developing innovative pharmaceutical formulations. It specializes in drug delivery solutions that enhance efficacy and convenience for patients.
